Whether Medicaid covers a weight loss shot depends entirely on which state you live in. Federal law includes a specific exception that allows state Medicaid programs to exclude drugs used for weight loss, even though they’re required to cover nearly all other FDA-approved medications. As of mid-2024, only 13 states covered GLP-1 medications for weight loss in their fee-for-service Medicaid programs, and that number is shrinking.
Why Most States Don’t Have to Cover Weight Loss Shots
Medicaid programs normally must cover almost every FDA-approved outpatient drug from manufacturers participating in the Medicaid Drug Rebate Program. Weight loss drugs are one of a small handful of exceptions carved out in federal statute. This means covering medications like Wegovy and Zepbound for obesity is entirely optional for each state.
This exception only applies when the drug is prescribed specifically for weight loss. The same medications prescribed for other conditions follow the normal rules. If your doctor prescribes a GLP-1 drug for type 2 diabetes, cardiovascular risk reduction, or obstructive sleep apnea, your state Medicaid program is generally required to cover it. The distinction comes down to the diagnosis code on your prescription, not the drug itself.
Which Shots Are Available (When States Do Cover Them)
The injectable weight loss medications that some state Medicaid programs cover include:
- Wegovy (semaglutide): FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Also approved to reduce cardiovascular risk in adults with established heart disease and obesity or overweight.
- Zepbound (tirzepatide): FDA-approved for chronic weight management under the same general criteria. Also approved for moderate to severe obstructive sleep apnea in adults with obesity.
- Saxenda (liraglutide): An older GLP-1 injection approved for weight management, though it produces less weight loss than the newer options.
In states that do provide coverage, these drugs typically appear on the state’s preferred drug list, and the state may favor one over the others based on cost negotiations with manufacturers. You won’t necessarily have a choice of which shot you get.
The Diabetes and Heart Disease Workaround
Even in states that don’t cover weight loss shots, Medicaid is required to cover GLP-1 medications prescribed for type 2 diabetes, cardiovascular disease, and sleep apnea. This is an important distinction. Ozempic (semaglutide) and Mounjaro (tirzepatide) are the diabetes-approved versions of the same active ingredients found in Wegovy and Zepbound, respectively.
If you have type 2 diabetes alongside obesity, your doctor can prescribe Ozempic or Mounjaro for diabetes management, and Medicaid must cover it. You’ll likely lose weight on these medications too, since they work through the same mechanism. Similarly, if you have established cardiovascular disease or obstructive sleep apnea along with obesity, Wegovy and Zepbound now carry FDA approvals for those conditions, which could make them coverable even in states that exclude weight-loss-only prescriptions.
North Carolina illustrates this trend clearly. As of October 2025, NC Medicaid no longer covers Wegovy or Zepbound solely for obesity treatment. But it still covers both drugs for reducing cardiovascular risk in adults with heart disease and obesity, for moderate to severe obstructive sleep apnea in adults with obesity, and for a specific liver condition called metabolic dysfunction-associated steatohepatitis. The diagnosis matters more than the drug.
Coverage Is Getting Harder to Find, Not Easier
The trend is moving in the wrong direction for people hoping Medicaid will pick up the cost. A Penn LDI study using June 2024 data found only 13 of 51 state Medicaid programs (including Washington, D.C.) covered GLP-1s for weight loss in adults. Pennsylvania eliminated its Medicaid coverage of GLP-1s for weight loss starting in January 2026. North Carolina dropped weight-loss-only coverage in late 2025. Other states may follow as budgets tighten.
The cost is the driving factor. These medications run over $1,000 per month at list price, and the number of eligible patients is enormous. State Medicaid directors have pushed back against proposals to make coverage mandatory, with the National Association of Medicaid Directors formally recommending that anti-obesity medication coverage remain optional rather than required.
One Exception: Children on Medicaid
Medicaid’s Early and Periodic Screening, Diagnostic and Treatment (EPSDT) benefit requires states to cover treatments deemed medically necessary for children and adolescents under 21. This means that even in states where adult weight loss drug coverage is excluded, a young person with severe obesity could potentially access these medications if a provider determines they are medically necessary. The process typically requires thorough documentation from the prescribing physician.
What You’ll Need for Approval
In the states that do cover weight loss shots, getting a prescription filled is rarely straightforward. Prior authorization is standard, meaning your doctor has to submit clinical documentation before the pharmacy can dispense the medication. This typically includes your BMI, a list of weight-related health conditions, and evidence that you’ve attempted other approaches first.
Many states also require step therapy, which means you may need to try a less expensive weight loss medication before the state will approve a GLP-1 injection. Your doctor submits the prior authorization request with the required clinical and administrative details, and the state’s Medicaid program or your managed care plan reviews it and issues a decision. Denials can be appealed, but the process adds weeks or months of delay.
How to Check Your State’s Coverage
Since coverage varies so widely, the most reliable step is checking your own state’s Medicaid drug formulary. Go to Medicaid.gov and use the state profiles tool, where you can select your state and access its prescription drug resources. Look for your state’s preferred drug list or prior approval criteria, which will spell out exactly which weight loss medications are covered and what clinical requirements apply.
If you’re enrolled in a Medicaid managed care plan rather than fee-for-service Medicaid, your plan may have a different formulary than the state’s baseline. Call the member services number on your Medicaid card and ask specifically whether GLP-1 medications for weight management are covered under your plan. Be prepared for the answer to depend on your specific diagnosis. A prescription tied to cardiovascular risk reduction or diabetes will follow a different coverage path than one written solely for obesity.